Aquilo Capital Management, LLC's Net Worth
$10.4 Million
Who is Aquilo Capital Management, LLC?
Aquilo Capital Management, LLC has an estimated net worth of $10.4 Million. This is based on reported shares across multiple companies, which include PIERIS PHARMACEUTICALS, INC., and Spero Therapeutics, Inc..
SEC CIK
Aquilo Capital Management, LLC's CIK is 0001591986
Past Insider Trading and Trends
2021 was Aquilo Capital Management, LLC's most active year for acquiring shares with 15 total transactions. Aquilo Capital Management, LLC's most active month to acquire stocks was the month of July. 2020 was Aquilo Capital Management, LLC's most active year for disposing of shares, totalling 7 transactions. Aquilo Capital Management, LLC's most active month to dispose stocks was the month of January. 2021 saw Aquilo Capital Management, LLC paying a total of $18,835,999.80 for 1,134,972 shares, this is the most they've acquired in one year. In 2020 Aquilo Capital Management, LLC cashed out on 2,464,933 shares for a total of $14,773,278.11, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Spero Therapeutics, Inc. (SPRO) Snapshot price: $1.43
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -35.74% | -1.90M |
$2.25 | -$4,279,611.54 | 3.42M |
Sep 22
| |||
Form 4
| +0.75% | 39.73K |
$5.24 | $207,970.85 | 5.32M |
Apr 26
| |||
Form 4
| +0.96% | 50K |
$8.79 | $439,420.00 | 5.28M |
Mar 30
| |||
Form 4
| +0.46% | 23.71K |
$7.63 | $180,797.21 | 5.23M |
Mar 14
| |||
Form 4
| +0.87% | 44.83K |
$9.53 | $427,227.11 | 5.21M |
Feb 28
| |||
Form 4
| +0.29% | 14.83K |
$9.24 | $137,038.89 | 5.16M |
Feb 18
| |||
Form 4
| +2.49% | 125K |
$11.59 | $1,448,262.50 | 5.15M |
Jan 31
| |||
Form 4
| +0.03% | 1.6K |
$10.89 | $17,418.07 | 5.02M |
Jan 24
| |||
Form 4
| +0.98% | 48.49K |
$12.41 | $601,963.97 | 5.02M |
Jan 18
| |||
Form 4
| +0.18% | 8.87K |
$12.93 | $114,608.64 | 4.97M |
Jan 10
| |||
Form 4
| +5.31% | 250.49K |
$15.42 | $3,862,897.82 | 4.96M |
Dec 29 - Dec 31
| |||
Form 4
| +3.29% | 150K |
$17.53 | $2,630,175.00 | 4.71M |
Oct 29
| |||
Form 4
| +3.04% | 134.54K |
$18.65 | $2,509,173.13 | 4.56M |
Sep 30
| |||
Form 4
| +1.06% | 46.37K |
$18.56 | $860,547.07 | 4.43M |
Sep 13 - Sep 14
| |||
Form 4
| +0.57% | 24.75K |
$18.50 | $457,792.15 | 4.38M |
Sep 9
| |||
Form 4
| +1.08% | 92.69K |
$18.40 | $1,707,518.91 | 8.67M |
Aug 30 - Aug 31
| |||
Form 4
| +0.87% | 36.94K |
$16.67 | $615,853.58 | 4.27M |
Aug 26 - Aug 27
| |||
Form 4
| +10.42% | 399.19K |
$15.51 | $6,192,042.14 | 4.23M |
Aug 20 - Aug 24
| |||
Form 4
| -0.08% | -3.00K |
$21.74 | -$65,215.20 | 3.83M |
Feb 8
| |||
Form 4
| -2.54% | -100.00K |
$19.02 | -$1,901,987.34 | 3.83M |
Feb 1 - Feb 4
| |||
Form 4
| -6.31% | -264.93K |
$18.80 | -$4,981,259.54 | 3.93M |
Dec 16 - Dec 17
| |||
Form 4
| -2.91% | -125.90K |
$13.77 | -$1,734,071.06 | 4.2M |
Nov 9
| |||
Form 4
| -3.87% | -174.10K |
$14.09 | -$2,452,947.51 | 4.32M |
Nov 4 - Nov 6
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
PIERIS PHARMACEUTICALS, INC. (PIRS) Snapshot price: $0.1719
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -34.08% | -1.90M |
$2.95 | -$5,605,000.00 | 3.68M |
Jul 21
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||